139 related articles for article (PubMed ID: 36517412)
1. Impact of the eicosapentaenoic acid to arachidonic acid ratio on plaque characteristics in statin-treated patients with coronary artery disease.
Asakura K; Minami Y; Nagata T; Katamine M; Katsura A; Hashimoto T; Kinoshita D; Ako J
J Clin Lipidol; 2023; 17(1):189-196. PubMed ID: 36517412
[TBL] [Abstract][Full Text] [Related]
2. Serum n-3 to n-6 polyunsaturated fatty acids ratio correlates with coronary plaque vulnerability: an optical coherence tomography study.
Hasegawa T; Otsuka K; Iguchi T; Matsumoto K; Ehara S; Nakata S; Nishimura S; Kataoka T; Shimada K; Yoshiyama M
Heart Vessels; 2014 Sep; 29(5):596-602. PubMed ID: 24005765
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma.
Nishio R; Shinke T; Otake H; Nakagawa M; Nagoshi R; Inoue T; Kozuki A; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Hiranuma N; Konishi A; Kinutani H; Shite J; Hirata K
Atherosclerosis; 2014 May; 234(1):114-9. PubMed ID: 24637411
[TBL] [Abstract][Full Text] [Related]
4. Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease.
Hashimoto T; Minami Y; Asakura K; Katamine M; Kato A; Katsura A; Sato T; Muramatsu Y; Kameda R; Meguro K; Shimohama T; Ako J
J Clin Lipidol; 2022; 16(1):104-111. PubMed ID: 34924352
[TBL] [Abstract][Full Text] [Related]
5. Higher triglyceride levels are associated with the higher prevalence of layered plaques in non-culprit coronary plaques.
Asakura K; Minami Y; Nagata T; Katamine M; Muramatsu Y; Kinoshita D; Ako J
J Thromb Thrombolysis; 2024 Jan; 57(1):58-66. PubMed ID: 37702855
[TBL] [Abstract][Full Text] [Related]
6. Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography.
Wakabayashi Y; Funayama H; Ugata Y; Taniguchi Y; Hoshino H; Ako J; Momomura S
J Cardiol; 2015 Dec; 66(6):482-8. PubMed ID: 25805011
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
[TBL] [Abstract][Full Text] [Related]
8. Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio.
Kashiyama T; Ueda Y; Nemoto T; Wada M; Masumura Y; Matsuo K; Nishio M; Hirata A; Asai M; Kashiwase K; Kodama K
Circ J; 2011; 75(10):2432-8. PubMed ID: 21778590
[TBL] [Abstract][Full Text] [Related]
9. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
[TBL] [Abstract][Full Text] [Related]
10. Association between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Characteristics of Plaque Rupture.
Sekimoto T; Koba S; Mori H; Arai T; Yamamoto MH; Mizukami T; Matsukawa N; Sakai R; Yokota Y; Sato S; Tanaka H; Masaki R; Oishi Y; Ogura K; Arai K; Nomura K; Sakai K; Tsujita H; Kondo S; Tsukamoto S; Suzuki H; Shinke T
J Atheroscler Thromb; 2023 Nov; 30(11):1687-1702. PubMed ID: 36967129
[TBL] [Abstract][Full Text] [Related]
11. Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels.
Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Murat Tuzcu E; Nissen SE; Nicholls SJ
Atherosclerosis; 2015 Oct; 242(2):490-5. PubMed ID: 26298740
[TBL] [Abstract][Full Text] [Related]
12. The impact of statins treatments for plaque characteristics in stable angina pectoris patients with very low and high low-density lipoprotein cholesterol levels: an intracoronary optical coherence tomography study.
Amano H; Kojima Y; Hirano S; Oka Y; Aikawa H; Noike R; Yabe T; Okubo R; Ikeda T
Heart Vessels; 2024 Jun; 39(6):475-485. PubMed ID: 38381169
[TBL] [Abstract][Full Text] [Related]
13. The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy.
Tani S; Nagao K; Kawauchi K; Yagi T; Atsumi W; Matsuo R; Hirayama A
Am J Cardiovasc Drugs; 2017 Oct; 17(5):409-420. PubMed ID: 28634822
[TBL] [Abstract][Full Text] [Related]
14. Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study.
Fujiyoshi K; Minami Y; Ishida K; Kato A; Katsura A; Muramatsu Y; Sato T; Kakizaki R; Nemoto T; Hashimoto T; Sato N; Meguro K; Shimohama T; Tojo T; Ako J
Atherosclerosis; 2019 Apr; 283():79-84. PubMed ID: 30802681
[TBL] [Abstract][Full Text] [Related]
15. Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.
Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Tuzcu EM; Nissen SE; Nicholls SJ
Eur J Prev Cardiol; 2015 Oct; 22(10):1331-9. PubMed ID: 26232281
[TBL] [Abstract][Full Text] [Related]
16. Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease.
Asakura K; Minami Y; Kinoshita D; Katamine M; Kato A; Katsura A; Sato T; Muramatsu Y; Hashimoto T; Kameda R; Meguro K; Shimohama T; Ako J
Int J Cardiol; 2022 Feb; 348():134-139. PubMed ID: 34896410
[TBL] [Abstract][Full Text] [Related]
17. Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study.
Chia S; Raffel OC; Takano M; Tearney GJ; Bouma BE; Jang IK
Coron Artery Dis; 2008 Jun; 19(4):237-42. PubMed ID: 18480667
[TBL] [Abstract][Full Text] [Related]
18. Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study.
Tani S; Yagi T; Matsuo R; Kawauchi K; Atsumi W; Matsumoto N; Okumura Y
J Cardiol; 2020 Nov; 76(5):487-498. PubMed ID: 32636128
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid.
John Chapman M; Preston Mason R
Pharmacol Ther; 2022 Dec; 240():108237. PubMed ID: 35772589
[TBL] [Abstract][Full Text] [Related]
20. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.
Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK
Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
